Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methotrexate in eosinophilic fasciitis
2006-003123-37Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in eosinophilic fasciitis (EF), sponsored by Radboud University Medical Center. Primary endpoints: Skin involvement score and Skin induration by durometer. Started Jun 2006; status: active.
02
Drugs
methotrexate
03
Conditions
eosinophilic fasciitis (EF)
Beyond the preview
Go deeper on 2006-003123-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003123-37.